Skip navigation

News & Events

Keep up to date on AgNovos events and related news

Archive - 2023

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE

AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.

Corporate Rebranding Announcement

AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience